EcoDrugPlus

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSPREG00000005719
Gene Symbol: DDR2
3 Cross references
204 Possible Orthologues:

Disintegrin And Metalloproteinase Domain-Containing Protein 17-Like

Ensembl ID : ENSPREG00000016988
Gene Symbol: LOC103458871
3 Cross references
208 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSPREG00000022345
Gene Symbol: DRD2
3 Cross references
208 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSPREG00000018785
Gene Symbol: DRD3
3 Cross references
203 Possible Orthologues:

Echinoderm Microtubule-Associated Protein-Like 4

Ensembl ID : ENSPREG00000013824
Gene Symbol: LOC103477445
2 Cross references
206 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSPREG00000021543
Gene Symbol: ENPP2
3 Cross references
226 Possible Orthologues:

Egl Nine Homolog 1

Ensembl ID : ENSPREG00000022839
Gene Symbol: LOC103474618
2 Cross references
191 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSPREG00000008372
Gene Symbol: EGLN1
3 Cross references
220 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSPREG00000002945
Gene Symbol: EGLN3
3 Cross references
198 Possible Orthologues:

Endothelial Pas Domain Protein 1b

Ensembl ID : ENSPREG00000005893
Gene Symbol: EPAS1B
1 Cross references
212 Possible Orthologues:

Endothelin B Receptor

Ensembl ID : ENSPREG00000023232
Gene Symbol: LOC103471340
3 Cross references
205 Possible Orthologues:

Endothelin Converting Enzyme 1

Ensembl ID : ENSPREG00000013927
Gene Symbol: ECE1
3 Cross references
230 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).